Tom H. Johnston

Increased 5‐HT_2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations

Philippe Huot, Tom H. Johnston, Tayyeba Darr et al. · Movement Disorders · 2010 · 154 citations

Life Sciences, Neurology, Neuroscience +17

Reduction of l-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease

Tom H. Johnston, Susan H. Fox, Matthew J. McIldowie et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 137 citations

Medicine, Neuroscience, Pharmacology +17

Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein

James B. Koprich, Tom H. Johnston, Philippe Huot et al. · PLoS ONE · 2011 · 110 citations · Full text

Life Sciences, Neurology, Neuroscience +16

Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease

Naomi P. Visanji, Jordi Gómez-Ramírez, Tom H. Johnston et al. · Movement Disorders · 2006 · 94 citations

Medicine, Neuroscience, Pharmacology +17

Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease

Naomi P. Visanji, Susan H. Fox, Tom H. Johnston et al. · Neurobiology of Disease · 2008 · 93 citations · Full text

Medicine, Neurobiology, Neuroscience +16